Type 2 diabetes, prediabetes, hypertension, dyslipidemia, sleep apnea, fatty liver disease, cardiovascular disease, and polycystic ovary syndrome all justify semaglutide therapy at a BMI of 27 or lower
Fatty Liver Disease Individuals with non-alcoholic fatty liver disease (NAFLD) may particularly benefit from retatrutide's glucagon-mediated hepatic fat reduction, which showed up to 81% liver fat reduction in trials
Eat foods rich in glutathione, such as spinach, avocados, asparagus and okra
This enhanced formulation combines Semaglutide , a powerful GLP-1 receptor agonist, with vitamin B12 to promote metabolic function, support energy levels, and reduce common side effects such as fatigue or nausea
"Mounjaro is a different type of medication, so I hoped it would suit me better
We do not manufacture, prescribe, or dispense medication